Nurse Practitioner, Women’s Health · Philadelphia, PA
NPI
1427358076
Since 2010
Specialty
Nurse Practitioner, Women’s Health
Code 363LW0102X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3400 Civic Center Blvd, West Pavilion, 3rd Floor
Philadelphia, PA, 19104
Phone (215) 662-2891
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,393
228 services
Medicare patients, 2024
146
Average age 73
Drug cost, 2024
$843K
2,754 prescriptions
Company payments, 2025
$4,049
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary Y Wang was code 99213 (office e&m - established), 108 times for 94 patients. In total Mary Y Wang billed 228 services in 12 codes, and Medicare paid $9,393.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 108 | 94 | $43.14 | $4,659 |
| 99212 Office E&M - Established | Facility | 35 | 12 | $21.53 | $753 |
| 99204 Office E&M - New | Facility | 21 | 21 | $83.30 | $1,749 |
| 99214 Office E&M - Established | Facility | 12 | 12 | $66.91 | $803 |
| 95972 Electrical Nerve Conductivity | Facility | 11 | 11 | $25.06 | $276 |
By year: 2022 $5,997 for 177 services; 2023 $8,067 for 208 services; 2024 $9,393 for 228 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary Y Wang prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 548 prescriptions and refills. In total Mary Y Wang wrote 2,754 Medicare prescriptions that cost $843K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 548 | 911 | 151 | $402K |
| Methenamine Hippurate Generic | 413 | 855 | 125 | $37K |
| Gemtesa Vibegron | 399 | 703 | 107 | $329K |
| Estradiol Generic | 231 | 625 | 127 | $13K |
| Cefpodoxime Proxetil Generic | 151 | 151 | 99 | $5,810 |
| Solifenacin Succinate Generic | 147 | 281 | 38 | $6,349 |
| Tamsulosin Hcl Generic | 142 | 307 | 50 | $2,669 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 95 | 95 | 79 | $1,081 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 92 | 92 | 79 | $282 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 82 | 173 | 25 | $3,666 |
| Trospium Chloride Er Trospium Chloride | 64 | 96 | 19 | $10K |
| Ciprofloxacin Hcl Generic | 38 | 38 | 29 | $191 |
| Trimethoprim Generic | 37 | 58 | Under 11 | $1,516 |
| Fluconazole Generic | 33 | 33 | 20 | $140 |
| Finasteride Generic | 27 | 57 | Under 11 | $469 |
Brand drugs: - claims; generic drugs: 1,709 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary Y Wang $4,049 ($4,049 in general payments such as food, travel and fees) from 8 companies. The largest payer was Coloplast Corp with $3,133.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.